Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phentolamines and their role in everyday dentistry
2020-000714-15Phase 4Terminated
- Sponsor
- Erasmus Hospital
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of phentolamine in carious lesion and pulpitis (2 arms), sponsored by Erasmus Hospital. Primary endpoint: Primary: Enrollment target. Started Feb 2020; status: terminated.
02
Drugs
phentolamine
03
Conditions
carious lesionpulpitis
Beyond the preview
Go deeper on 2020-000714-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000714-15.